Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8750
-0.0250 (-1.32%)
NASDAQ· Last Trade: May 14th, 3:04 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors